Egalet jumps on data for abuse-deterrent morphine

Egalet Corp. (NASDAQ:EGLT) climbed $1.18 (24%) to $6.11 on topline data from a human abuse liability study showing that 60 mg Egalet-001,

Read the full 229 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE